Antibacterial activity of cefamandole in vitro
- PMID: 349095
- DOI: 10.1093/infdis/137.supplement.s25
Antibacterial activity of cefamandole in vitro
Abstract
Cefamandole, a new cephalosporin derivative, was found to have a broad spectrum of antimicrobial activity against a cross-section of both gram-positive and gram-negative bacteria isolated clinically. Gram-positive cocci, except for Streptococcus faecalis, were extremely susceptible to cefamandole; penicillin G-resistant Staphylococcus aureus also was highly susceptible. Minimal bactericidal concentrations for gram-positive cocci approximated the minimal inhibitory concentrations. Strains of Haemophilus influenzae were very susceptible to the drug. Most strains of Escherichia coli, Klebsiella species, and Proteus species were inhibited by low concentrations of cefamandole, Salmonella typhi, including ampicillin- and chloramphenicol-resistant strains, was inhibited by low concentrations of cefamandole. Susceptible bacteria became increasingly resistant as the inoculum size was increased. Strains of Pseudomonas were resistant to cefamandole.
Similar articles
-
Cefamandole: antimicrobial activity in vitro of a new cephalosporin.Antimicrob Agents Chemother. 1975 Dec;8(6):737-41. doi: 10.1128/AAC.8.6.737. Antimicrob Agents Chemother. 1975. PMID: 1044248 Free PMC article.
-
In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.Infection. 1980;8 Suppl 3:S 330-3. doi: 10.1007/BF01639606. Infection. 1980. PMID: 6447672
-
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273. Antimicrob Agents Chemother. 1980. PMID: 6247970 Free PMC article.
-
Bacterial resistance to penicillins and cephalosporins.Proc R Soc Lond B Biol Sci. 1971 Dec 31;179(1057):403-10. doi: 10.1098/rspb.1971.0105. Proc R Soc Lond B Biol Sci. 1971. PMID: 4401418 Review. No abstract available.
-
Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.Pharmacotherapy. 1982 Nov-Dec;2(6):322-7. doi: 10.1002/j.1875-9114.1982.tb03208.x. Pharmacotherapy. 1982. PMID: 6762529 Review.
Cited by
-
Cefamandole therapy in anaerobic infections.Antimicrob Agents Chemother. 1979 Mar;15(3):337-41. doi: 10.1128/AAC.15.3.337. Antimicrob Agents Chemother. 1979. PMID: 380458 Free PMC article. Clinical Trial.
-
Pharmacokinetics and safety of cefamandole in newborn infants.Antimicrob Agents Chemother. 1979 May;15(5):674-6. doi: 10.1128/AAC.15.5.674. Antimicrob Agents Chemother. 1979. PMID: 525985 Free PMC article.
-
Evaluation of the Cathra inoculating device for susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.Antimicrob Agents Chemother. 1982 Nov;22(5):901-2. doi: 10.1128/AAC.22.5.901. Antimicrob Agents Chemother. 1982. PMID: 6924824 Free PMC article.
-
Pharmacology, Safety, and efficacy of cefamandole in childhood infections.Antimicrob Agents Chemother. 1981 Jul;20(1):21-4. doi: 10.1128/AAC.20.1.21. Antimicrob Agents Chemother. 1981. PMID: 7283413 Free PMC article.
-
Pharmacokinetics and safety of cefamandole in infants and children.Antimicrob Agents Chemother. 1978 Dec;14(6):838-41. doi: 10.1128/AAC.14.6.838. Antimicrob Agents Chemother. 1978. PMID: 570372 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources